Document Detail

Surgery in soft tissue sarcoma: more conservative in extremities, more extended in the retroperitoneum.
MedLine Citation:
PMID:  23030226     Owner:  NLM     Status:  In-Data-Review    
Extremity soft-tissue sarcomas (ESTS) account for approximately 50% and retroperitoneal soft-tissue sarcomas (RSTS) for approximately15% of all soft-tissue sarcomas. Surgery remains the main treatment modality for all soft-tissue sarcomas. Neoadjuvant and/or adjuvant chemo-and radiation-therapy are also often used to improve the treatment outcomes. In ESTS, surgery had originally been mutilating. The introduction of principles of surgical adequacy and of complementary treatments, especially radiotherapy, led to a reduction in the amputation rate in favor of conservative treatments. The implementation of plastic, vascular and nerve reconstructions allowed for further increase in conservative procedures, with better functional and cosmetic results. Moreover, recent reports have demonstrated how preoperative treatments can offset the negative prognostic impact of marginal resection on local outcome and survival, extending the limit of limb and function preservation. In RSTS, surgery had consisted of simple excision, while the resection of surrounding organs/viscera had been considered only in cases of direct involvement/infiltration. This strategy was associated with a high rate of local recurrence, which in many cases it was the driving cause of death. In order to improve local control and subsequent overall survival, some authors have recently advocated a policy of extended surgery including surrounding organs/viscera en bloc with the tumor. In this review, the authors discuss the standard world wide accepted surgical treatment for ESTS and the new surgical approach for RSTS.
Chiara Colombo; R Lor Randall; Robert Hi Andtbacka; Alessandro Gronchi
Related Documents :
24039186 - The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiratio...
23539246 - Complications associated with injectable soft-tissue fillers: a 5-year retrospective re...
23475746 - The role of fascial slings in the treatment of stress urinary incontinence in women: a ...
11432136 - Post vasectomy analysis: call for a uniform evidence-based protocol.
938076 - Physiatrics for deforming linear scleroderma.
24829036 - Surgical treatment of microprolactinomas: pros.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of anticancer therapy     Volume:  12     ISSN:  1744-8328     ISO Abbreviation:  Expert Rev Anticancer Ther     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101123358     Medline TA:  Expert Rev Anticancer Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1079-87     Citation Subset:  IM    
Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of surgery in the multidisciplinary management of patients with localized gastrointestinal ...
Next Document:  Optimizing further treatment choices in short- and long-term responders to first-line therapy for pa...